Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S3W-37870 · Session 3

Further to the answer to question S3W-36953 by Nicola Sturgeon on 9 November 2010, whether it will commit to using the Barnett consequentia…

Answered Asked by Bill Butler Lab Lodged 25 Nov 2010

The question

To ask the Scottish Executive, further to the answer to question S3W-36953 by Nicola Sturgeon on 9 November 2010, whether it will commit to using the Barnett consequential funding resulting from the £200 million per year cancer drug fund for cancer drugs.

The answer

Answered by Nicola Sturgeon on 6 Dec 2010 · 11 days after it was lodged, on time

The consequentials on the full NHS (health) settlement in England are allocated to the Scottish Government on a total budget basis with no specific policies ring-fenced. The Scottish Government will give due consideration to the Department of Health cancer drugs fund consultation findings once they are published.
Scotland has robust, equitable and transparent arrangements for the introduction of newly licensed clinically and cost-effective medicines to treat all conditions. These arrangements include opportunities at national level to consider additional factors to facilitate, in certain circumstances, a flexible appraisal of clinical and cost-effective evidence. They also include opportunities at local level for clinically led consideration of medicines for individual patients in certain circumstances.

In the Official Report

No contribution in the Official Report cites S3W-37870 by reference.